PeptideStack
5.2kquestions
20kanswers
220users

If I reconstitute a 10 mg vial with 5 mL of 0.9% sodium chloride, what concentration do I end up with?

Asked 14 Apr 2025Modified 12 months agoViewed 23k times
12

Concretely: 10 mg · 5 mL · 0.9% sodium chloride.

I want the working, not the result — I need to be able to redo it with different numbers.

I care about the precision as well as the value — I want to know how many figures are real.

Is my approach right even if my number is wrong?

reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

313 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
shareeditfollowflag
DV
askeddead_volume56k4814 Apr 2025
2Worth stating whether you have a content assay, because the calculation assumes label claim. – sample_id 6 months ago
Same question, and I got two answers that differ by a factor of ten, so I am watching this. – plate_count_9k 4 months ago
add a comment

5 Answers

Sorted by votes
60

10 ÷ 5 = 2 mg/mL. Concentration is vial content divided by diluent volume, so 10 mg of peptide in 5 mL of 0.9% sodium chloride gives 2 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.02 mg — 20 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.

The answer depends on what you want your measurement resolution to be, and that is a real trade-off rather than a preference. More diluent gives you more syringe marks per dose and therefore less rounding error; it also gives you a larger volume to keep cold and a longer period over which the solution has to remain within specification.

If the material arrived warm and it was lyophilised, test it and proceed on the result.

Check the barrel marking, not your memory of it.

The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
LC
answeredlyoph_cake78k2673 May 2025
8Adding a vote because this deserves more of them. – v_ramaswamy 4 months ago
7The arithmetic checks out. I ran the same numbers and got the same result. – marta_okonkwo 2 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
39

Before anything else: a kitchen counter with an alcohol wipe is not an aseptic environment, and it is worth being honest about that rather than pretending the procedure is something it is not. What you are doing is reducing bioburden, not achieving sterility.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.

Number of stopper piercings matters less than the gauge doing the piercing.

Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

edited 21 May 2025 by tabular_nums — added the placebo-arm figures

shareimprove this answerflag
TN
answeredtabular_nums71k4814 May 2025
29

If the supplier documentation specifies a diluent, there is usually a reason, and if it specifies nothing, water for injection is the conservative default.

Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.

The caveat on all of this is that it assumes the vial contains what the label says.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
TM
answeredtobias_maartens171k3589 Aug 2025
Adding that a fixed-needle syringe loses about a tenth of what a luer one does. – Dr_Marek_Zielinski 5 months ago
Does this change at lower concentrations, or does adsorption start to dominate? – Dr_Ingrid_Baumgartner 3 months ago
add a comment
23

Mechanically, reconstitution is the step where most hands-on errors enter the system, which is why spending time on technique here pays off more than anywhere else.

Do not use the same needle to pierce the stopper and to administer.

The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.

Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.

shareimprove this answerflag
FV
answeredfill_volume22k3822 Apr 2025
4Minor: the filter membrane chemistry matters as much as the pore size for adsorption. – rune_thoresen 3 months ago
add a comment
23

The part that matters: add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.

On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.

Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.

One limitation: technique reduces risk, it does not remove it.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale against the barrel rather than against your assumption.

shareimprove this answerflag
BC
answeredbea_castellanos24k12717 Jul 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.